1,417
Views
2
CrossRef citations to date
0
Altmetric
Hematology

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial

, &
Article: 2224044 | Received 06 Jun 2022, Accepted 03 Jun 2023, Published online: 15 Jun 2023